These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24699624)

  • 21. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
    Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
    Hayun M; Naor Y; Weil M; Albeck M; Peled A; Don J; Haran-Ghera N; Sredni B
    Biochem Pharmacol; 2006 Nov; 72(11):1423-31. PubMed ID: 16889755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The matricellular ligand Cyr61 contributes to the metastatic spread of tumors by activating integrin VLA-4, independently of thiol redox modulation
.
    Hoß SG; Schlesinger M; Bendas G
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):682-685. PubMed ID: 27509825
    [No Abstract]   [Full Text] [Related]  

  • 24. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation.
    Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC
    Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
    Martelli AM; Nyåkern M; Tabellini G; Bortul R; Tazzari PL; Evangelisti C; Cocco L
    Leukemia; 2006 Jun; 20(6):911-28. PubMed ID: 16642045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
    Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
    Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tellurium compound AS101 induces PC12 differentiation and rescues the neurons from apoptotic death.
    Makarovsky D; Kalechman Y; Sonino T; Freidkin I; Teitz S; Albeck M; Weil M; Geffen-Aricha R; Yadid G; Sredni B
    Ann N Y Acad Sci; 2003 Dec; 1010():659-66. PubMed ID: 15033807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
    Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
    J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction therapy in a multiple myeloma mouse model using a combination of AS101 and melphalan, and the activity of AS101 in a tumor microenvironment model.
    Hayun M; Saida H; Albeck M; Peled A; Haran-Ghera N; Sredni B
    Exp Hematol; 2009 May; 37(5):593-603. PubMed ID: 19375650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.
    Sredni B; Weil M; Khomenok G; Lebenthal I; Teitz S; Mardor Y; Ram Z; Orenstein A; Kershenovich A; Michowiz S; Cohen YI; Rappaport ZH; Freidkin I; Albeck M; Longo DL; Kalechman Y
    Cancer Res; 2004 Mar; 64(5):1843-52. PubMed ID: 14996748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice.
    Carmely A; Meirow D; Peretz A; Albeck M; Bartoov B; Sredni B
    Hum Reprod; 2009 Jun; 24(6):1322-9. PubMed ID: 19240057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway.
    Zheng J; Hu JD; Chen YY; Chen BY; Huang Y; Zheng ZH; Liu TB
    Asian Pac J Cancer Prev; 2012; 13(4):1119-24. PubMed ID: 22799292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.
    Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L
    Curr Med Chem; 2007; 14(19):2009-23. PubMed ID: 17691943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.
    Okun E; Dikshtein Y; Carmely A; Saida H; Frei G; Sela BA; Varshavsky L; Ofir A; Levy E; Albeck M; Sredni B
    FEBS J; 2007 Jun; 274(12):3159-70. PubMed ID: 17521335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells.
    Bertacchini J; Frasson C; Chiarini F; D'Avella D; Accordi B; Anselmi L; Barozzi P; Forghieri F; Luppi M; Martelli AM; Basso G; Najmaldin S; Khosravi A; Rahim F; Marmiroli S
    Adv Biol Regul; 2018 May; 68():2-9. PubMed ID: 29576448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
    Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM
    Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.
    Karajannis MA; Vincent L; Direnzo R; Shmelkov SV; Zhang F; Feldman EJ; Bohlen P; Zhu Z; Sun H; Kussie P; Rafii S
    Leukemia; 2006 Jun; 20(6):979-86. PubMed ID: 16598308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium.
    Ling D; Liu B; Jawad S; Thompson IA; Nagineni CN; Dailey J; Chien J; Sredni B; Nussenblatt RB
    Br J Ophthalmol; 2013 Jul; 97(7):934-8. PubMed ID: 23624272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals.
    Bendall LJ; Makrynikola V; Hutchinson A; Bianchi AC; Bradstock KF; Gottlieb DJ
    Leukemia; 1998 Sep; 12(9):1375-82. PubMed ID: 9737685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.